Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hikma Pharmaceuticals Plc (HKMPF : OTC)
 
 • Company Description   
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.

Number of Employees: 9,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $27.73 Daily Weekly Monthly
20 Day Moving Average: 141 shares
Shares Outstanding: 221.89 (millions)
Market Capitalization: $6,152.93 (millions)
Beta: 0.57
52 Week High: $28.92
52 Week Low: $22.56
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -3.74%
12 Week 5.86% -10.96%
Year To Date 14.97% 7.67%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1 New Burlington Place
-
London,X0 W1S 2HR
GBR		 ph: 44-20-7399-2760
fax: 44-0-20-7399-2761		 investors@hikma.uk.com http://www.hikma.com
 
 • General Corporate Information   
Officers
Said Darwazah - Executive Chairman and Chief Executive Officer
Mazen Darwazah - Executive Vice Chairman
Khalid Nabilsi - Chief Financial Officer
Bassam Kanaan - Executive Vice President
Hussein Arkhagha - Chief Counsel and Company Secretary

Peer Information
Hikma Pharmaceuticals Plc (GSAC)
Hikma Pharmaceuticals Plc (CASI)
Hikma Pharmaceuticals Plc (ALCD.)
Hikma Pharmaceuticals Plc (OMNN)
Hikma Pharmaceuticals Plc (CGPI.)
Hikma Pharmaceuticals Plc (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: G4576K104
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 221.89
Most Recent Split Date: (:1)
Beta: 0.57
Market Capitalization: $6,152.93 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 3.46%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.96
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 2.65
Price/Cash Flow: 12.43
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 1.14
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - 0.65
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - 14.55
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - 10.46
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - 1.78
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - 0.28
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - 21.96
 

Powered by Zacks Investment Research ©